Passage Bio, Inc.
PASG
$7.48
-$0.065-0.86%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -17.92% | -15.46% | -17.48% | -13.71% | -17.34% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -29.18% | -28.45% | -28.93% | -27.31% | -21.83% |
| Operating Income | 29.18% | 28.45% | 28.93% | 27.31% | 21.83% |
| Income Before Tax | 25.75% | 24.84% | 36.54% | 38.78% | 31.61% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 25.75% | 24.84% | 36.54% | 38.78% | 31.61% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 25.75% | 24.84% | 36.54% | 38.78% | 31.61% |
| EBIT | 29.18% | 28.45% | 28.93% | 27.31% | 21.83% |
| EBITDA | 28.45% | 28.37% | 29.43% | 27.71% | 22.22% |
| EPS Basic | 32.30% | 33.39% | 42.62% | 43.10% | 34.11% |
| Normalized Basic EPS | 36.21% | 37.68% | 36.82% | 33.78% | 26.91% |
| EPS Diluted | 32.30% | 33.39% | 42.66% | 43.13% | 34.15% |
| Normalized Diluted EPS | 36.21% | 37.68% | 36.82% | 33.78% | 26.91% |
| Average Basic Shares Outstanding | 8.87% | 12.66% | 10.87% | 7.83% | 4.79% |
| Average Diluted Shares Outstanding | 8.87% | 12.66% | 10.87% | 7.83% | 4.79% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |